Erratum: DR2 blocker thioridazine: A promising drug for ovarian cancer therapy.
Erratum: DR2 blocker thioridazine: A promising drug for ovarian cancer therapy.
Oncol Lett. 2020 Nov;20(5):218
Authors: Yong M, Yu T, Tian S, Liu S, Xu J, Hu J, Hu L
Abstract
[This corrects the article DOI: 10.3892/ol.2017.7184.].
PMID: 32963624 [PubMed]
Source: Oncology Letters - Category: Cancer & Oncology Tags: Oncol Lett Source Type: research